Close Menu

Over at Genetic Future, Daniel MacArthur is wondering what everyone wants to know: why buy Navigenics' Annual Insight service for $500 when you can have 23andMe's full genome scan for $100 cheaper? Navigenics recently announced an alternative to its $2,500 genetic testing service, the Annual Insight service, which costs $499 and analyzes genetic predisposition for ten common health conditions, including breast cancer, prostate cancer, colon cancer, and heart disease.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

An Associated Press report says China refrained from releasing the SARS-CoV-2 genome for more than a week in January, frustrating the World Health Organization.

The Lancet and the New England Journal of Medicine have issued expressions of concern regarding the data used in two COVID-19 papers, the New York Times reports. 

Researchers have sequenced the genome of the mayfly, garnering insight into how insects evolved wings, Science reports.

In Genome Research this week: gene expression in primate brain regions, inversions and breakpoint inverted repeats in the human genome, and more.